Forecast Of The Day: Colgate-Palmolive’s Oral, Home, and Personal Care Revenues

+1.37%
Upside
80.34
Market
81.44
Trefis
CL: Colgate Palmolive logo
CL
Colgate Palmolive

What?

Colgate-Palmolive’s (NYSE:CL) Oral, Home, and Personal Care Revenues rose from $13.2 billion in 2019 to about $13.7 billion in 2020. Trefis expects the metric to rise to about $14.5 billion in 2021 and to around $14.9 billion in 2022.

Why?

Relevant Articles
  1. Colgate-Palmolive Stock Has Returned Just 6% Since Late 2017- Here’s Why
  2. Colgate-Palmolive Stock Has Underperformed The S&P Since 2018- Here’s Why
  3. Up 8% Last Month, Colgate-Palmolive Stock Looks Unlikely To Continue Its Rally
  4. Can Colgate-Palmolive Stock Sustain Its Outperformance?
  5. Colgate-Palmolive Stock Looks Unlikely To Continue Its Rally Next Month
  6. Here’s Why Colgate-Palmolive Is A Strong Consumer Bet

While growth picked recently due to the Covid-19 pandemic and the stay-at-home trend, we expect longer-term growth to be driven by innovation-led new product launches and higher pricing.

So What?

We don’t think the projected growth is priced into CL stock yet. We value CL at about $86 per share, about 13% ahead of the current market price.

See Our Complete Analysis For Colgate-Palmolive

Invest with Trefis Market-Beating Portfolios
See all Trefis Price Estimates